文献速递乳腺MR乳腺X线

COVID-19大流行对乳腺活检延迟的影响:疫情前、停摆期与停摆后差异的相关因素

Impact of the COVID-19 Pandemic on Breast Biopsy Delays: Factors Contributing to Disparities Across Prepandemic, Shutdown, and Postshutdown Periods.
PubMed 文献 · J Am Coll Radiol · 2025-05-13

这项回顾性队列研究纳入2019年1月1日至2021年12月31日一家多站点学术机构的4415次BI-RADS 4或5类评估、建议影像引导下乳腺活检的检查,分析疫情前、停摆期与停摆后活检延迟的相关因素。结果显示从诊断检查到活检的中位时间由疫情前11天增至停摆后16天(P<.001),显著延迟(≥30天)由9%增至12%(P=.001);停摆后时期独立预测延迟(OR 1.4,P=.004),年龄较大、少数族裔、失业、无保险及未婚患者延迟更常见。

要点

  • 疫情前至停摆后,从诊断检查到活检的中位时间由11天增至16天(P<.001)。
  • 显著延迟(≥30天)由疫情前9%增至停摆后12%(P=.001),停摆后时期独立预测延迟(OR 1.4,P=.004)。
  • 年龄≥70岁、黑人、亚裔、失业、无保险、未婚及接受立体定向或MRI活检为延迟的显著预测因素。

核心结论

  • 疫情前至停摆后,乳腺活检延迟增加。
  • 研究期间,年龄较大、少数族裔、失业、无保险及未婚患者的显著延迟更常见,停摆后时期独立预测显著延迟。

研究设计与样本

  • 回顾性队列研究,纳入一家多站点学术机构2019年1月1日至2021年12月31日的4415次检查(4197例患者),均为BI-RADS 4或5类评估并建议影像引导下活检。
  • 按时期分组:疫情前(2019年1月1日至2020年2月29日,n=1551)、停摆期(2020年3月1日至2020年5月31日,n=170)、停摆后(2020年6月1日至2021年12月31日,n=2694)。
  • 采用t检验、Wilcoxon秩和检验及单因素和多因素logistic回归分析活检延迟的相关因素。

诊断标准与关键数值

  • 显著活检延迟定义为从诊断检查到活检≥30天。
  • 中位活检时间:疫情前11天 vs 停摆后16天(P<.001)。
  • 显著延迟(≥30天)比例:疫情前9% vs 停摆后12%(P=.001)。
  • 当日活检比例:疫情前8% vs 停摆期24%(P<.001),停摆后降至2%(P<.001)。
  • 多因素分析中停摆后时期与延迟独立相关(OR 1.4,P=.004)。

临床应用与阅片要点

  • 报告BI-RADS 4或5类建议活检时,可对照原文所列延迟预测因素(年龄60–70岁OR 1.5、≥70岁OR 1.9、黑人OR 1.6、亚裔OR 1.9、无个人乳腺癌史OR 1.4、失业OR 1.5、无保险OR 2.7、未婚OR 1.4、立体定向活检OR 1.3、MRI活检OR 4.7)识别延迟风险较高的患者。
  • 原文结论指出,这些发现凸显需要持续干预以减轻医疗中断的影响,尤其针对弱势人群,以确保在未来医疗危机期间及恢复期及时作出乳腺癌诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The coronavirus disease of 2019 pandemic significantly disrupted health care delivery, leading to delays in diagnostic procedures.

OBJECTIVE: This study aimed to examine the factors associated with delays in time from diagnostic examination to image-guided breast biopsies during the prepandemic, shutdown, and postshutdown periods.

METHODS: This retrospective cohort study included 4,415 examinations with a BI-RADS 4 or 5 assessment recommending image-guided biopsy for 4,197 patients at a multisite academic institution from January 1, 2019, to December 31, 2021. Delays in biopsy were assessed across three periods: prepandemic (January 1, 2019, to February 29, 2020, n = 1,551), shutdown (March 1, 2020, to May 31, 2020, n = 170), and postshutdown (June 1, 2020, to December 31, 2021, n = 2,694). Patient factors included age, race, ethnicity, personal or family history of breast cancer, area deprivation index, employment, insurance, and marital status. Clinical factors included BI-RADS assessment and biopsy modality. t Tests, Wilcoxon's rank-sum tests, and univariate and multivariate logistic regression analyses were performed to quantify and identify factors associated with biopsy delay.

RESULTS: The median time to biopsy from diagnostic examination significantly increased between the prepandemic (11 days) and postshutdown (16 days) periods (P < .001). Significant biopsy delays, defined as ≥30 days to biopsy, increased between the prepandemic (9%) and postshutdown (12%) periods (P = .001). Compared with the prepandemic period, same-day biopsies increased in the shutdown period (from 8% to 24%, P < .001) due to institutional implementation of same-day procedures during the shutdown, then sharply declined in the postshutdown period (2%, P < .001). Biopsies were independently more likely to be delayed in the postshutdown period compared with the prepandemic period on multivariate analysis (odds ratio [OR] 1.4, P = .004). In addition to time period, patient factors including age between 60 and 70 years (OR 1.5, P = .020) or ≥70 years (OR 1.9, P = .002), Black (OR 1.6, P < .001) or Asian (OR 1.9, P = .003) race, not having a personal history of breast cancer (OR 1.4, P = .018), being unemployed (OR 1.5, P = .005) or uninsured (OR 2.7, P = .001), being unmarried (OR 1.4, P = .004), and undergoing stereotactic (OR 1.3, P = .013) or MRI (OR 4.7, P < .001) biopsies were significant predictors of delay in the prepandemic and postshutdown periods on multivariate analysis.

CONCLUSIONS: Delays in breast biopsies increased between the prepandemic and postshutdown periods. Significant delays were more prevalent among older, racial minority, unemployed, uninsured, and unmarried patients during the study period, with the postshutdown period independently predicting significant delays.

CLINICAL IMPACT: These findings highlight the need for continued interventions to mitigate the effects of health care disruptions, particularly for vulnerable populations, to ensure timely breast cancer diagnoses during and in the recovery period following future health care crises.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Panigrahi B, Ghuman N, Rossi J, et al. Impact of the COVID-19 Pandemic on Breast Biopsy Delays: Factors Contributing to Disparities Across Prepandemic, Shutdown, and Postshutdown Periods. J Am Coll Radiol. 2025. PMID: 40373985. doi:10.1016/j.jacr.2025.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。